Phosphate Binders in CKD: ‟New Kids on the Block”

Аутори

  • Muhammad Umair Afzal
  • Shafeeq Cheema Jinah Hospital, Lahore

##doi.readerDisplayName##:

https://doi.org/10.53778/pjkd31089

Кључне речи:

hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxide

Апстракт

Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.

PJKD

##submission.downloads##

Објављено

2021-02-05

Број часописа

Год. 3 Бр. 10 (2019): Pakistan Journal of Kidney Diseases

Рубрика

Review Article

Лиценца

Сва права задржана (c) 2021 Muhammad Umair Afzal, Shafeeq Cheema

Creative Commons License

Овај рад је под Creative Commons Aуторство-Nекомерцијално 4.0 Интернационална лиценца.

Како цитирати

Phosphate Binders in CKD: ‟New Kids on the Block”. (2021). Pakistan Journal of Kidney Diseases, 3(10). https://doi.org/10.53778/pjkd31089